Literature DB >> 30003346

De novo gastroesophageal reflux disease after sleeve gastrectomy: role of preoperative silent reflux.

Yves Borbély1, Esther Schaffner2, Lara Zimmermann2, Michael Huguenin2, Gabriel Plitzko2, Philipp Nett2, Dino Kröll2.   

Abstract

BACKGROUND: Laparoscopic sleeve gastrectomy (LSG) has become the most frequently performed bariatric procedure to date. However, LSG is known to worsen pre-operative and result in de novo gastroesophageal reflux disease (GERD). Pre-operative evaluation reveals a high percentage of silent GERD of so far unknown influence on post-operative GERD.
METHODS: Prospective data of patients undergoing primary LSG between 01/2012 and 12/2015 were evaluated. Pre-operative GERD-specific evaluation consisted of validated questionnaires, upper endoscopy, 24 h-pH-manometry, and esophagograms. Patients were followed-up with questionnaires every 6 months, upper endoscopies after 1 year and 24 h-pH-metry after 2 years. Silent GERD was defined as esophagitis grade > B and/or abnormal esophageal acid exposure in absence of symptoms. LSG was performed over a 32F bougie, hiatal hernias > 1 cm were addressed with posterior hiatoplasty. Excluded were patients with hiatal hernias > 4 cm, patients with incorrect anatomy (stenosis, fundus too large) and conversion to RYGB for early leaks.
RESULTS: 222 patients were included. Mean follow-up was 32 ± 16 months, mean preoperative body mass index 49.6 ± 7.2 kg/m2. 116 patients (52%) presented with post-operative GERD-symptoms, of which 85 (73%) had de novo symptoms. Of those, 48 (of 85, 56%) had no preoperative GERD and 37 (of 85, 44%) silent GERD. 57 patients (26%) had neither pre- nor post-operative GERD, 7 (3%) had silent pre-operative and no postop GERD, and in 19 patients (9%) GERD was cured with LSG. 31 patients (14%) stayed symptomatic. Of 56 patients (25%) with pre-operative silent GERD, 37 (of 54, 66%) became symptomatic.
CONCLUSION: LSG leads to a considerable rate of post-operative GERD. De novo-GERD consist of around half of pre-operative silent GERD and completely de novo-GERD. Most patients with pre-operative silent GERD became symptomatic.

Entities:  

Keywords:  24-h pH-monitoring; Asymptomatic diseases; Body mass index; Gastroesophageal reflux disease; Obesity; Sleeve gastrectomy

Mesh:

Year:  2018        PMID: 30003346     DOI: 10.1007/s00464-018-6344-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  39 in total

1.  Laparoscopic sleeve gastrectomy leads the U.S. utilization of bariatric surgery at academic medical centers.

Authors:  J Esteban Varela; Ninh T Nguyen
Journal:  Surg Obes Relat Dis       Date:  2015-02-12       Impact factor: 4.734

2.  Autonomic nerve dysfunction is closely associated with the abnormalities of esophageal motility in reflux esophagitis.

Authors:  N Manabe; K Haruma; J Hata; K Nakamura; S Tanaka; K Chayama
Journal:  Scand J Gastroenterol       Date:  2003-02       Impact factor: 2.423

3.  Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Yi-Chia Lee; Chi-Yang Chang; Ching-Tai Lee; Jaw-Town Lin
Journal:  Surg Endosc       Date:  2012-12-12       Impact factor: 4.584

4.  24-h Multichannel Intraluminal Impedance PH-metry 1 Year After Laparocopic Sleeve Gastrectomy: an Objective Assessment of Gastroesophageal Reflux Disease.

Authors:  Doulami Georgia; Triantafyllou Stamatina; Natoudi Maria; Albanopoulos Konstantinos; Filis Konstantinos; Leandros Emmanouil; Zografos Georgios; Theodorou Dimitrios
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

5.  Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy.

Authors:  Gustavo A Arman; Jacques Himpens; Jeroen Dhaenens; Thierry Ballet; Ramon Vilallonga; Guido Leman
Journal:  Surg Obes Relat Dis       Date:  2016-01-19       Impact factor: 4.734

6.  The development of the GERD-HRQL symptom severity instrument.

Authors:  V Velanovich
Journal:  Dis Esophagus       Date:  2007       Impact factor: 3.429

7.  Autonomic nerve dysfunction in pathologically obese patients.

Authors:  E Surrenti; G Ciancio; S Carloppi; M Lucchese; A Coppola; R Caramelli; C Surrenti
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

Review 8.  Gastro-oesophageal reflux disease and obesity: pathogenesis and response to treatment.

Authors:  François Mion; Jérôme Dargent
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-07-21       Impact factor: 3.043

9.  Does laparoscopic sleeve gastrectomy have any influence on gastroesophageal reflux disease? Preliminary results.

Authors:  Verónica Gorodner; Rudolf Buxhoeveden; Gastón Clemente; Laura Solé; Luis Caro; Alejandro Grigaites
Journal:  Surg Endosc       Date:  2014-10-11       Impact factor: 4.584

10.  Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014.

Authors:  L Angrisani; A Santonicola; P Iovino; A Vitiello; N Zundel; H Buchwald; N Scopinaro
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

View more
  17 in total

1.  Predictive Factors of Gastroesophageal Reflux Disease in Bariatric Surgery: a Controlled Trial Comparing Sleeve Gastrectomy with Gastric Bypass.

Authors:  Daniel Navarini; Carlos Augusto S Madalosso; Alexandre P Tognon; Fernando Fornari; Fábio R Barão; Richard R Gurski
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

2.  Surgeon variation in severity of reflux symptoms after sleeve gastrectomy.

Authors:  Oliver A Varban; Jyothi R Thumma; Dana A Telem; Nabeel R Obeid; Jonathan F Finks; Amir A Ghaferi; Justin B Dimick
Journal:  Surg Endosc       Date:  2019-06-18       Impact factor: 4.584

3.  Optimizing bariatric surgery outcomes: a novel preoperative protocol in a bariatric population with gastroesophageal reflux disease.

Authors:  Rhys Kavanagh; Jessica Smith; Umair Bashir; Dana Jones; Emily Avgenakis; Peter Nau
Journal:  Surg Endosc       Date:  2019-06-25       Impact factor: 4.584

4.  Gastroesophageal Reflux After Sleeve Gastrectomy: New Onset and Effect on Symptoms on a Prospective Evaluation.

Authors:  Vincenzo Pilone; Salvatore Tramontano; Michele Renzulli; Claudio Zulli; Luigi Schiavo
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

Review 5.  Gastroesophageal Cancer After Gastric Bypass Surgeries: a Systematic Review and Meta-analysis.

Authors:  Rodrigue Chemaly; Samer Diab; Georges Khazen; Georges Al-Hajj
Journal:  Obes Surg       Date:  2022-01-27       Impact factor: 4.129

6.  Gastroesophageal Reflux Disease, Esophagitis, and Barrett's Esophagus 3 to 4 Years Post Sleeve Gastrectomy.

Authors:  Samer Elkassem
Journal:  Obes Surg       Date:  2021-10-02       Impact factor: 4.129

7.  Can Omentopexy Reduce the Incidence of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy.

Authors:  Saeid Shams Nosrati; Abdolreza Pazouki; Mohammad Sabzikarian; Mohammadali Pakaneh; Ali Kabir; Mohammad Kermansaravi
Journal:  Obes Surg       Date:  2020-08-18       Impact factor: 4.129

Review 8.  The Effect of Laparoscopic Sleeve Gastrectomy on Gastroesophageal Reflux Disease.

Authors:  Flavia Carvalho Silveira; Christina Poa-Li; Matthew Pergamo; Akash Gujral; Sindhura Kolli; George A Fielding; Christine J Ren-Fielding; Bradley F Schwack
Journal:  Obes Surg       Date:  2020-11-26       Impact factor: 4.129

9.  Trends in Bariatric Surgery: a 5-Year Analysis of the Israel National Bariatric Surgery Registry.

Authors:  Uri Kaplan; Orly Romano-Zelekha; David Goitein; Dean Keren; Ian M Gralnek; Lital Keinan Boker; Nasser Sakran
Journal:  Obes Surg       Date:  2020-05       Impact factor: 4.129

10.  The Impact of Sleeve Gastrectomy on Gastroesophageal Reflux Disease in Patients with Morbid Obesity.

Authors:  Cristina Sancho Moya; Marcos Bruna Esteban; Javier Sempere García-Argüelles; Luis Ferrer Barceló; Ana Monzó Gallego; Beatriz Mirabet Sáez; Claudia Mulas Fernández; Pilar Albors Bagá; Antonio Vázquez Prado; Miguel Oviedo Bravo; Eva Montalvá Orón
Journal:  Obes Surg       Date:  2022-01-20       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.